White House To End COVID Emergency Declarations in May
By

By
The White House has announced its intention to extend the COVID-19 national emergency and public health emergency until May 11, 2023, at which point, both the national and public health…

World Health Organization Says COVID-19 Still a Public Health Emergency, But in Transition
By

By
The World Health Organization (WHO)’s Director-General, Dr. Tedros Adhanom Ghebreyesus, reported earlier this week (January 30, 2023) that the COVID-19 pandemic “continues to constitute a public health emergency of international…

Roche Names New Pharma Chief 
By

By
Roche has appointed Teresa Graham, the current Head of Global Product Strategy for Roche Pharmaceuticals, as the new CEO of Roche Pharmaceuticals, effective March 2023. With the appointment, she will…

Amgen Launches First Biosimilar of AbbVie’s Humira
By

By
Amgen has announced that Amjevita (adalimumab-atto), a biosimilar to AbbVie’s Humira (adalimumab), is now available in the US. Humira had 2021 sales of $20.69 billion and was AbbVie’s highest selling…

Supplier News:, Euroapi, Seqens, Mikart & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Euroapi, Seqens, Mikart, Vector BioMed, Sanner, and Jones Healthcare.   Chemicals/Chemical API Manufacturing * Euroapi Resumes Prostaglandin Production at Budapest Site * Seqens Opens R&D…

Lilly To Invest $450 M in North Carolina Mfg Site
By

By
Eli Lilly and Company has announced plans to invest an additional $450 million to expand its manufacturing site in Research Triangle Park, North Carolina. The expansion includes additional parenteral filling,…

EU Officials Address Shortages of Antibiotics in the EU
By

By
European Union (EU) officials are moving to address recent shortages of  antibiotics, particularly amoxicillin, in the EU and outlined recent action to address manufacturing and supply issues.   “Shortages of medicines…

Supplier News: Catalent, Experic, Stevanato & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Catalent, Experic, Stevanato, and Colorcon.  Biologics Manufacturing * Catalent Opens Plasmid DNA Mfg Facility Formulation Development/Drug Product Manufacturing * Experic Adds New Analytical Lab * Colorcon…

Global Briefs: Takeda, Sandoz, Astellas, Vir & More
By

By
A roundup of news from Takeda, Hutchmed, Torrent Pharmaceuticals, Sandoz, Astellas, Vir Biotechnology, Sanofi and CytoReason. Highlights below.   * Takeda, Hutchmed in $1.13-Bn Licensing Pact for Cancer Drug   * FDA…

Pfizer To Acquire Biomanufacturing Facility from CDMO Abzena
By

By
Pfizer has agreed to acquire a biomanufacturing facility in Sanford, North Carolina from Abzena, a San Diego, California-based CDMO of biologics and antibody drug conjugates,   The new Sanford, North Carolina…